Phthalazinone derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S116000, C544S237000, C514S234500

Reexamination Certificate

active

11233311

ABSTRACT:
Compounds of formula Itheir pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates are disclosed. Also disclosed are methods for the preparation of the above-mentioned compounds, pharmaceutical compositions containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.

REFERENCES:
patent: 6207401 (2001-03-01), Plowman et al.
patent: 1 051 500 (2000-11-01), None
patent: WO 95/19169 (1995-07-01), None
patent: WO 95/23141 (1995-08-01), None
patent: WO 97/022702 (1997-06-01), None
patent: WO 97/42187 (1997-11-01), None
patent: WO 99/06396 (1999-02-01), None
patent: WO 00/05219 (2000-02-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21595 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/55116 (2001-08-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 02/22601 (2002-03-01), None
patent: WO 02/22602 (2002-03-01), None
patent: WO 02/22603 (2002-03-01), None
patent: WO 02/22604 (2002-03-01), None
patent: WO 02/22605 (2002-03-01), None
patent: WO 02/22606 (2002-03-01), None
patent: WO 02/22607 (2002-03-01), None
patent: WO 02/22608 (2002-06-01), None
patent: WO 02/50065 (2002-06-01), None
patent: WO 02/50066 (2002-06-01), None
patent: WO 02/057259 (2002-07-01), None
patent: WO 02/059111 (2002-08-01), None
patent: WO 02/059112 (2002-08-01), None
patent: WO 02/062789 (2002-08-01), None
patent: WO 02/066461 (2002-08-01), None
patent: WO 02/068415 (2002-09-01), None
patent: WO 02/96905 (2002-12-01), None
patent: WO 03/015785 (2003-02-01), None
patent: WO 03/055491 (2003-07-01), None
patent: WO 03/077921 (2003-09-01), None
patent: WO 03/078423 (2003-09-01), None
patent: WO 03/078426 (2003-09-01), None
patent: WO 03/078427 (2003-09-01), None
patent: WO 04/000833 (2003-12-01), None
patent: WO 04/005283 (2004-01-01), None
Adams, R.R., et al, Trends Cell Biol. 11 (2001) 49-54.
Bischoff, J.R. and Plowman, G.D., Trends Cell Biol. 9 (1999) 454-459.
Giet, R., and Prigent, C., J. Cell Sci. 112 (1999) 3591-3601.
Harrington, E.A. et al, Nat. Med. 10 (2004) 262-267.
Hunter, T., Cell 50 (1987) 823-829.
Isola, J.J. et al., Am. J. Pathol. 147 (1995) 905-911.
Nigg, E.A., Nat. Rev. Mol. cell Biol. 2 (2001) 21-32.
Sen, S. et al, J. Natl. Cancer Inst. 94 (2002) 1320-1329.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phthalazinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phthalazinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phthalazinone derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3835420

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.